Literature DB >> 1645365

New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.

T F Schwarz1, S Modrow, B Hottenträger, B Höflacher, G Jäger, W Scharti, R Sumazakl, H Wolf, J Middeldorp, M Roggendorf.   

Abstract

A new, highly sensitive and specific enzyme immunoassay using oligopeptides as antigen (enzyme-linked immunosorbent assay [ELISA] B19-OP) for detecting parvovirus B19-specific immunoglobulin G (IgG) was established. As antigens, B19-specific oligopeptides of 24 and 30 kDa derived from a 196-kDa fusion protein of beta-galactosidase and viral capsid protein (VPI) of B19 after CNBr cleavage and separation by high-pressure liquid chromatography were used. Of 139 serum specimens tested in parallel for anti-B19 IgG by standard ELISA using B19 particles as antigen and by ELISA B19-OP, 73 (52.5%) were positive and 63 (45.3%) were negative in both tests, and 3 (2.2%) were negative by standard ELISA but positive by ELISA B19-OP and by immunoblot. By using ELISA B19-OP, it was possible to detect anti-B19 IgG in an asymptomatic blood donor 4 weeks after acute infection, and anti-B19 IgG titers of 10(-5) could be measured in convalescent-phase sera.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645365      PMCID: PMC269794          DOI: 10.1128/jcm.29.3.431-435.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia.

Authors:  G J Kurtzman; B Cohen; P Meyers; A Amunullah; N S Young
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

2.  A new peptide for human parvovirus B19 antibody detection.

Authors:  E Fridell; J Trojnar; B Wahren
Journal:  Scand J Infect Dis       Date:  1989

3.  Laboratory infection with parvovirus B19.

Authors:  B J Cohen; A M Couroucé; T F Schwarz; K Okochi; G J Kurtzman
Journal:  J Clin Pathol       Date:  1988-09       Impact factor: 3.411

4.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates.

Authors:  O Bartolomei Corsi; A Azzi; M Morfini; R Fanci; P Rossi Ferrini
Journal:  J Med Virol       Date:  1988-06       Impact factor: 2.327

6.  Human parvovirus B19 infection in pregnancy.

Authors:  T F Schwarz; M Roggendorf; B Hottenträger; F Deinhardt; G Enders; K P Gloning; T Schramm; M Hansmann
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

7.  The human parvovirus. Brief review.

Authors:  M J Anderson; J R Pattison
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

8.  A genetically engineered cell line that produces empty capsids of B19 (human) parvovirus.

Authors:  S Kajigaya; T Shimada; S Fujita; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

10.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

View more
  4 in total

1.  Determination of the optimal cutoff value for a serological assay: an example using the Johne's Absorbed EIA.

Authors:  S E Ridge; A L Vizard
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

2.  Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.

Authors:  L Kaikkonen; H Lankinen; I Harjunpää; K Hokynar; M Söderlund-Venermo; C Oker-Blom; L Hedman; K Hedman
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay.

Authors:  M Söderlund; K E Brown; O Meurman; K Hedman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.